DOCSLIB.ORG

L'bel RENOVÂNCE JOUR Drug Facts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
L'bel RENOVÂNCE JOUR Drug Facts LBEL PARIS RENOVANCE JOUR- octinoxate, octocrylene, and oxybenzone cream Ventura International LTD Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. ---------- L'BEL RENOVÂNCE JOUR Drug Facts Active Ingredients Octinoxate (7.5 %), Octocrylene (5 %), Oxybenzone (3 %) Purpose Sunscreen Uses Helps prevent sunburn Higher SPF gives more sunburn protection Provides moderate protection against sunburn Warnings For external use only. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash and irritation develops and lasts. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Directions Apply smoothly every morning before sun exposure and as needed. Children under 6 months of age: ask a doctor. Other information Moderate sun protection product. Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risk of skin cancer, and other harmful effects of the sun. Inactive ingredients Aqua (water), cyclohexasiloxane, soy protein phthalate, glycerin, pisum sativum (pea) extract, c12-15 alkyl benzoate, caprylic / capric triglyceride, cyclopentasiloxane, cetyl alcohol, cetearyl alcohol, isopropyl myristate, isononyl isononanoate, sorbitan stearate, mannitol, glyceryl stearate, potassium cetyl phosphate, dimethicone / vinyl dimethicone crosspolymer, dimethicone crosspolymer, triethanolamine, acrylates / c10-30 alkyl acrylate crosspolymer, ceteareth-20, propylparaben, panthenol, sodium pca, steareth-20, ceteth-20, parfum (fragance), ci 77891 (titanium dioxide), chlorphenesin, dimethiconol, teprenone, ppg-26-buteth-26, polysorbate 80, peg-40 hydrogenated castor oil, tetrasodium edta, cyclodextrin, butylene glycol, hydrolyzed algin, hedera helix (ivy) leaf / stem extract, faex extract (yeast extract), magnesium pca, chlorella vulgaris extract, maris aqua (sea water), algin, tocopheryl acetate, zinc pca, retinyl palmitate, saccharomyces / magnesium ferment, ascorbyl palmitate, serine, urea, acacia, senegal gum, bioflavonoids, allantoin, disodium succinate, saccharomyces /iron ferment, manganese pca, saccharomyces /copper ferment, saccharomyces /calcium ferment, saccharomyces /silicon ferment, saccharomyces /zinc ferment. US: Distributed by Ventura International Ltd. San Francisco, CA 94111 PRINCIPAL DISPLAY PANEL - 50 g Jar Carton L'BEL RENOVÂNCE JOUR intensive refining, fortifying and renewing treatment spf 15 daytime face and neck cream 50 g e (1.7 oz.) LBEL PARIS RENOVANCE JOUR octinoxate, octocrylene, and oxybenzone cream Product Information Product T ype HUMAN OTC DRUG Ite m Code (Source ) NDC:1478 3-0 38 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength O ctino xa te (UNII: 4Y5P7MUD51) (Octino xate - UNII:4Y5P7MUD51) Octino xate 3.75 g in 50 g O cto crylene (UNII: 5A6 8 WGF6 WM) (Octo crylene - UNII:5A6 8 WGF6 WM) Octo crylene 2.5 g in 50 g O xybenzo ne (UNII: 9 5OOS7VE0 Y) (Oxybenzo ne - UNII:9 5OOS7VE0 Y) Oxybenzo ne 1.5 g in 50 g Inactive Ingredients Ingredient Name Strength wa ter (UNII: 0 59 QF0 KO0 R) cyclo methico ne 6 (UNII: XHK3U310 BA) g lycerin (UNII: PDC6 A3C0 OX) sno w pea (UNII: 8 4SKC33B1I) c12 -15 a lkyl benzo a te (UNII: A9 EJ3J6 1HQ) medium-cha in trig lycerides (UNII: C9 H2L21V7U) cyclo methico ne 5 (UNII: 0 THT5PCI0 R) cetyl a lco ho l (UNII: 9 36 JST6 JCN) ceto stea ryl a lco ho l (UNII: 2DMT128 M1S) iso pro pyl myrista te (UNII: 0 RE8 K4LNJS) iso no nyl iso no na no a te (UNII: S4V5BS6 GCX) so rbita n mo no stea ra te (UNII: NVZ4I0 H58 X) ma nnito l (UNII: 3OWL53L36 A) g lyceryl mo no stea ra te (UNII: 230 OU9 XXE4) po ta ssium cetyl pho spha te (UNII: 0 3KCY6 P7UT) tro la mine (UNII: 9 O3K9 3S3TK) po lyo xyl 2 0 ceto stea ryl ether (UNII: YRC528 SWUY) pro pylpa ra ben (UNII: Z8 IX2SC1OH) pa ntheno l (UNII: WV9 CM0 O6 7Z) so dium pyrro lido ne ca rbo xyla te (UNII: 46 9 OTG57A2) stea reth-2 0 (UNII: L0 Q8 IK9 E0 8 ) ceteth-2 0 (UNII: I8 35H2IHHX) chlo rphenesin (UNII: I6 70 DAL4SZ) tita nium dio xide (UNII: 15FIX9 V2JP) tepreno ne (UNII: S8 S8 451A4O) po lyso rba te 8 0 (UNII: 6 OZP39 ZG8 H) po lyo xyl 4 0 hydro g ena ted ca sto r o il (UNII: 7YC6 8 6 GQ8 F) edeta te so dium (UNII: MP1J8 420 LU) butylene g lyco l (UNII: 3XUS8 5K0 RA) ka lmia la tifo lia lea f (UNII: 79 N6 542N18 ) yea st (UNII: 3NY3SM6 B8 U) vita min a pa lmita te (UNII: 1D1K0 N0 VVC) a sco rbyl pa lmita te (UNII: QN8 3US2B0 N) serine (UNII: 452VLY9 40 2) urea (UNII: 8 W8 T178 47W) a ca cia (UNII: 5C540 3N26 O) a lla nto in (UNII: 344S277G0 Z) so dium succina te a nhydro us (UNII: V8 ZGC8 ISR3) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:1478 3-0 38 -6 1 1 in 1 BOX 1 NDC:1478 3-0 38 -6 2 50 g in 1 JAR Marketing Information Marke ting Cate gory Application Numbe r or Monograph Citation Marke ting Start Date Marke ting End Date OTC MONOGRAPH FINAL part352 0 8 /15/20 10 LBEL PARIS RENOVANCE JOUR octinoxate, octocrylene, and oxybenzone cream Product Information Product T ype HUMAN OTC DRUG Ite m Code (Source ) NDC:1478 3-0 28 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength O ctino xa te (UNII: 4Y5P7MUD51) (Octino xate - UNII:4Y5P7MUD51) Octino xate 0 .375 g in 5 g O cto crylene (UNII: 5A6 8 WGF6 WM) (Octo crylene - UNII:5A6 8 WGF6 WM) Octo crylene 0 .25 g in 5 g O xybenzo ne (UNII: 9 5OOS7VE0 Y) (Oxybenzo ne - UNII:9 5OOS7VE0 Y) Oxybenzo ne 0 .15 g in 5 g Inactive Ingredients Ingredient Name Strength wa ter (UNII: 0 59 QF0 KO0 R) cyclo methico ne 6 (UNII: XHK3U310 BA) g lycerin (UNII: PDC6 A3C0 OX) sno w pea (UNII: 8 4SKC33B1I) c12 -15 a lkyl benzo a te (UNII: A9 EJ3J6 1HQ) medium-cha in trig lycerides (UNII: C9 H2L21V7U) cyclo methico ne 5 (UNII: 0 THT5PCI0 R) cetyl a lco ho l (UNII: 9 36 JST6 JCN) ceto stea ryl a lco ho l (UNII: 2DMT128 M1S) iso pro pyl myrista te (UNII: 0 RE8 K4LNJS) iso no nyl iso no na no a te (UNII: S4V5BS6 GCX) so rbita n mo no stea ra te (UNII: NVZ4I0 H58 X) ma nnito l (UNII: 3OWL53L36 A) g lyceryl mo no stea ra te (UNII: 230 OU9 XXE4) po ta ssium cetyl pho spha te (UNII: 0 3KCY6 P7UT) tro la mine (UNII: 9 O3K9 3S3TK) po lyo xyl 2 0 ceto stea ryl ether (UNII: YRC528 SWUY) pro pylpa ra ben (UNII: Z8 IX2SC1OH) pa ntheno l (UNII: WV9 CM0 O6 7Z) so dium pyrro lido ne ca rbo xyla te (UNII: 46 9 OTG57A2) stea reth-2 0 (UNII: L0 Q8 IK9 E0 8 ) ceteth-2 0 (UNII: I8 35H2IHHX) chlo rphenesin (UNII: I6 70 DAL4SZ) tita nium dio xide (UNII: 15FIX9 V2JP) tepreno ne (UNII: S8 S8 451A4O) po lyso rba te 8 0 (UNII: 6 OZP39 ZG8 H) po lyo xyl 4 0 hydro g ena ted ca sto r o il (UNII: 7YC6 8 6 GQ8 F) edeta te so dium (UNII: MP1J8 420 LU) butylene g lyco l (UNII: 3XUS8 5K0 RA) ka lmia la tifo lia lea f (UNII: 79 N6 542N18 ) yea st (UNII: 3NY3SM6 B8 U) vita min a pa lmita te (UNII: 1D1K0 N0 VVC) a sco rbyl pa lmita te (UNII: QN8 3US2B0 N) serine (UNII: 452VLY9 40 2) urea (UNII: 8 W8 T178 47W) a ca cia (UNII: 5C540 3N26 O) a lla nto in (UNII: 344S277G0 Z) so dium succina te a nhydro us (UNII: V8 ZGC8 ISR3) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:1478 3-0 28 -51 1 in 1 BOX 1 NDC:1478 3-0 28 -52 5 g in 1 JAR Marketing Information Marke ting Cate gory Application Numbe r or Monograph Citation Marke ting Start Date Marke ting End Date OTC MONOGRAPH FINAL part352 0 8 /15/20 10 LBEL PARIS RENOVANCE JOUR octinoxate, octocrylene, and oxybenzone cream Product Information Product T ype HUMAN OTC DRUG Ite m Code (Source ) NDC:1478 3-0 18 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength O ctino xa te (UNII: 4Y5P7MUD51) (Octino xate - UNII:4Y5P7MUD51) Octino xate 0 .0 75 g in 1 g O cto crylene (UNII: 5A6 8 WGF6 WM) (Octo crylene - UNII:5A6 8 WGF6 WM) Octo crylene 0 .0 5 g in 1 g O xybenzo ne (UNII: 9 5OOS7VE0 Y) (Oxybenzo ne - UNII:9 5OOS7VE0 Y) Oxybenzo ne 0 .0 3 g in 1 g Inactive Ingredients Ingredient Name Strength wa ter (UNII: 0 59 QF0 KO0 R) cyclo methico ne 6 (UNII: XHK3U310 BA) g lycerin (UNII: PDC6 A3C0 OX) sno w pea (UNII: 8 4SKC33B1I) c12 -15 a lkyl benzo a te (UNII: A9 EJ3J6 1HQ) medium-cha in trig lycerides (UNII: C9 H2L21V7U) cyclo methico ne 5 (UNII: 0 THT5PCI0 R) cetyl a lco ho l (UNII: 9 36 JST6 JCN) ceto stea ryl a lco ho l (UNII: 2DMT128 M1S) iso pro pyl myrista te (UNII: 0 RE8 K4LNJS) iso no nyl iso no na no a te (UNII: S4V5BS6 GCX) so rbita n mo no stea ra te (UNII: NVZ4I0 H58 X) ma nnito l (UNII: 3OWL53L36 A) g lyceryl mo no stea ra te (UNII: 230 OU9 XXE4) po ta ssium cetyl pho spha te (UNII: 0 3KCY6 P7UT) tro la mine (UNII: 9 O3K9 3S3TK) po lyo xyl 2 0 ceto stea ryl ether (UNII: YRC528 SWUY) pro pylpa ra ben (UNII: Z8 IX2SC1OH) pa ntheno l (UNII: WV9 CM0 O6 7Z) so dium pyrro lido ne ca rbo xyla te (UNII: 46 9 OTG57A2) stea reth-2 0 (UNII: L0 Q8 IK9 E0 8 ) ceteth-2 0 (UNII: I8 35H2IHHX) chlo rphenesin (UNII: I6 70 DAL4SZ) tita nium dio xide (UNII: 15FIX9 V2JP) tepreno ne (UNII: S8 S8 451A4O) po lyso rba te 8 0 (UNII: 6 OZP39 ZG8 H) po lyo xyl 4 0 hydro g ena ted ca sto r o il (UNII: 7YC6 8 6 GQ8 F) edeta te so dium (UNII: MP1J8 420 LU) butylene g lyco l (UNII: 3XUS8 5K0 RA) ka lmia la tifo lia lea f (UNII: 79 N6 542N18 ) yea st (UNII: 3NY3SM6 B8 U) vita min a pa lmita te (UNII: 1D1K0 N0 VVC) a sco rbyl pa lmita te (UNII: QN8 3US2B0 N) serine (UNII: 452VLY9 40 2) urea (UNII: 8 W8 T178 47W) a ca cia (UNII: 5C540 3N26 O) a lla nto in (UNII: 344S277G0 Z) so dium succina te a nhydro us (UNII: V8 ZGC8 ISR3) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:1478 3-0 18 -41 1 in 1 BOX 1 NDC:1478 3-0 18 -42 1 g in 1 JAR Marketing Information Marke ting Cate gory Application Numbe r or Monograph Citation Marke ting Start Date Marke ting End Date OTC MONOGRAPH FINAL part352 0 8 /15/20 10 Labeler - Ventura International LT D (603192787) Revised: 8/2010 Ventura International LTD.
Load more

Recommended publications
  • L'bel DÉFENSE 365 OIL-FREE DAILY PROTECTIVE FACIAL LOTION SPF 50 Drug Facts
    LBEL DEFENSE 365 DAILY PROTECTIVE SPF 50- octinoxate, titanium dioxide, homosalate, octisalate, oxybenzone, and zinc oxide lotion Ventura International LTD Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. ---------- L'BEL DÉFENSE 365 OIL-FREE DAILY PROTECTIVE FACIAL LOTION SPF 50 Drug Facts Active Ingredients Purpose Homosalate (5.00%) Sunscreen Octinoxate (7.00%) Sunscreen Octisalate (5.00%) Sunscreen Oxybenzone (4.00%) Sunscreen Titanium dioxide (6.24%) Sunscreen Zinc oxide (3.92%) Sunscreen Uses Helps prevent sunburn. Warnings Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Directions Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours. Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor. Other information Protect the product in this container from excessive heat and direct sun. Inactive ingredients Water, dicaprylyl carbonate, propylheptyl caprylate, glyceryl
    [Show full text]
  • Ventura/Lompoc Smart Card Demonstration Evaluation: Final Report Volume 1 Technical Performance, User Response, and Institutional Analysis Genevieve Giuliano, James E
    CALIFORNIA PATH PROGRAM INSTITUTE OF TRANSPORTATION STUDIES UNIVERSITY OF CALIFORNIA, BERKELEY Ventura/Lompoc Smart Card Demonstration Evaluation: Final Report Volume 1 Technical Performance, User Response, and Institutional Analysis Genevieve Giuliano, James E. Moore II, Jacqueline Golob California PATH Research Report UCB-ITS-PRR-99-30 This work was performed as part of the California PATH Program of the University of California, in cooperation with the State of California Business, Transportation, and Housing Agency, Department of Transportation; and the United States Department of Transportation, Federal Highway Administration. The contents of this report reflect the views of the authors who are responsible for the facts and the accuracy of the data presented herein. The contents do not necessarily reflect the official views or policies of the State of California. This report does not constitute a standard, specification, or regulation. Report for RTA 65V313-7 August 1999 ISSN 1055-1425 CALIFORNIA PARTNERS FOR ADVANCED TRANSIT AND HIGHWAYS Ventura/Lompoc Smart Card Demonstration Evaluation: Final Report Volume 1 Technical Performance, User Response, and Institutional Analysis Genevieve Giuliano, James E. Moore II, Jacqueline Golob Research Report MOU RTA 65V313-7 July 1999 DISCLAIMER This work was performed as part of the California PATH Program of the University of California, in cooperation with the State of California Business, Transportation, and Housing Agency, Department of Transportation; and the United States Department of Transportation, Federal Highway Administration. The contents of this report reflect the views of the authors who are responsible for the facts and the accuracy of the data presented herein. The contents do not necessarily reflect the official views or policies of the State of California.
    [Show full text]
  • User Guide 7206 Thermal Printer
    User Guide 7206 Thermal Printer 7206 CONTENTS Before Operation INTRODUCTION -------------------------------------------------------------------- 3 COMPLIANCE STATEMENT FOR EUROPEAN USERS----------------------------- 4 FCC COMPLIANCE STATEMENT FOR AMERICAN USERS ----------------------- 4 EMI COMPLIANCE STATEMENT FOR CANADIAN USERS------------------------ 5 ETAT DE CONFORMITE EMI A L’USAGE DES UTILISATEURS CANADIENS ----- 5 IMPORTANT SAFETY INSTRUCTIONS--------------------------------------------- 6 NOTICE ------------------------------------------------------------------------------- 7 SAFETY INSTRUCTIONS ------------------------------------------------------------ 8 Chapter 1 Setup Confirmation of Carton Contents -------------------------------------------------10 Part Names and Functions---------------------------------------------------------- 11 Connection to Power---------------------------------------------------------------17 Driver Installation -------------------------------------------------------------------17 Connection to a Computer--------------------------------------------------------18 Chapter 2 Printer Operation Power ON/OFF ----------------------------------------------------------------------19 Normal Operating Mode ---------------------------------------------------------- 20 Setting the Media ------------------------------------------------------------------ 22 Setting the Ribbon ----------------------------------------------------------------- 26 Mode Settings ----------------------------------------------------------------------
    [Show full text]
  • IGP® / VGL Emulation Code V™ Graphics Language Programmer's Reference Manual Line Matrix Series Printers
    IGP® / VGL Emulation Code V™ Graphics Language Programmer’s Reference Manual Line Matrix Series Printers Trademark Acknowledgements IBM and IBM PC are registered trademarks of the International Business Machines Corp. HP and PCL are registered trademarks of Hewlett-Packard Company. IGP, LinePrinter Plus, PSA, and Printronix are registered trademarks of Printronix, LLC. QMS is a registered trademark and Code V is a trademark of Quality Micro Systems, Inc. CSA is a registered certification mark of the Canadian Standards Association. TUV is a registered certification mark of TUV Rheinland of North America, Inc. UL is a registered certification mark of Underwriters Laboratories, Inc. This product uses Intellifont Scalable typefaces and Intellifont technology. Intellifont is a registered trademark of Agfa Division, Miles Incorporated (Agfa). CG Triumvirate are trademarks of Agfa Division, Miles Incorporated (Agfa). CG Times, based on Times New Roman under license from The Monotype Corporation Plc is a product of Agfa. Printronix, LLC. makes no representations or warranties of any kind regarding this material, including, but not limited to, implied warranties of merchantability and fitness for a particular purpose. Printronix, LLC. shall not be held responsible for errors contained herein or any omissions from this material or for any damages, whether direct, indirect, incidental or consequential, in connection with the furnishing, distribution, performance or use of this material. The information in this manual is subject to change without notice. This document contains proprietary information protected by copyright. No part of this document may be reproduced, copied, translated or incorporated in any other material in any form or by any means, whether manual, graphic, electronic, mechanical or otherwise, without the prior written consent of Printronix, LLC.
    [Show full text]
  • Ocи Power Print Controller
    Océ Power Print Controller PCL5e Reference Guide Océ-Technologies B.V. This manual reflects software release 4.3 of the Océ Power Print Controller. Trademarks Products in this manual are referred to by their trade names. In most, if not all cases, these designations are claimed as trademarks or registered trademarks of their respective companies. Xionics Document Technologies, the Xionics logo and PhoenixPage are trademarks of Xionics. Copyright Océ-Technologies B.V. Venlo, The Netherlands © 2000 All rights reserved. No part of this work may be reproduced, copied, adapted, or transmitted in any form or by any means without written permission from Océ. Océ-Technologies B.V. makes no representation or warranties with respect to the contents hereof and specifically disclaims any implied warranties of merchantability or fitness for any particular purpose. Further, Océ-Technologies B.V. reserves the right to revise this publication and to make changes from time to time in the content hereof without obligation to notify any person of such revision or changes. Edition 2.0 GB Contents Chapter 1 Introduction For who is this Reference Guide intended? 8 End users and Key Operators 8 Programmers 8 Structure of this PCL5e Reference Guide 9 Overview of chapters 9 Additional documentation 10 Additional PCL documentation 10 Additional Océ printer documentation 10 User interfaces 11 Chapter 2 PCL implementation PCL implementation in the Océ Power Print Controller 14 Printing files using the PCL PDL 14 Printer commands 14 HP PCL5 emulation 16 PCL compatibility
    [Show full text]
  • 2015Suspension 2008Registere
    LIST OF SEC REGISTERED CORPORATIONS FY 2008 WHICH FAILED TO SUBMIT FS AND GIS FOR PERIOD 2009 TO 2013 Date SEC Number Company Name Registered 1 CN200808877 "CASTLESPRING ELDERLY & SENIOR CITIZEN ASSOCIATION (CESCA)," INC. 06/11/2008 2 CS200719335 "GO" GENERICS SUPERDRUG INC. 01/30/2008 3 CS200802980 "JUST US" INDUSTRIAL & CONSTRUCTION SERVICES INC. 02/28/2008 4 CN200812088 "KABAGANG" NI DOC LOUIE CHUA INC. 08/05/2008 5 CN200803880 #1-PROBINSYANG MAUNLAD SANDIGAN NG BAYAN (#1-PRO-MASA NG 03/12/2008 6 CN200831927 (CEAG) CARCAR EMERGENCY ASSISTANCE GROUP RESCUE UNIT, INC. 12/10/2008 CN200830435 (D'EXTRA TOURS) DO EXCEL XENOS TEAM RIDERS ASSOCIATION AND TRACK 11/11/2008 7 OVER UNITED ROADS OR SEAS INC. 8 CN200804630 (MAZBDA) MARAGONDONZAPOTE BUS DRIVERS ASSN. INC. 03/28/2008 9 CN200813013 *CASTULE URBAN POOR ASSOCIATION INC. 08/28/2008 10 CS200830445 1 MORE ENTERTAINMENT INC. 11/12/2008 11 CN200811216 1 TULONG AT AGAPAY SA KABATAAN INC. 07/17/2008 12 CN200815933 1004 SHALOM METHODIST CHURCH, INC. 10/10/2008 13 CS200804199 1129 GOLDEN BRIDGE INTL INC. 03/19/2008 14 CS200809641 12-STAR REALTY DEVELOPMENT CORP. 06/24/2008 15 CS200828395 138 YE SEN FA INC. 07/07/2008 16 CN200801915 13TH CLUB OF ANTIPOLO INC. 02/11/2008 17 CS200818390 1415 GROUP, INC. 11/25/2008 18 CN200805092 15 LUCKY STARS OFW ASSOCIATION INC. 04/04/2008 19 CS200807505 153 METALS & MINING CORP. 05/19/2008 20 CS200828236 168 CREDIT CORPORATION 06/05/2008 21 CS200812630 168 MEGASAVE TRADING CORP. 08/14/2008 22 CS200819056 168 TAXI CORP.
    [Show full text]
  • Mercury User Manual Version 10.0 Mercury User Manual
    Mercury User Manual Version 10.0 Mercury User Manual All rights reserved. No parts of this work may be reproduced in any form or by any means - graphic, electronic, or mechanical, including photocopying, recording, taping, or information storage and retrieval systems - without the written permission of the publisher. Products that are referred to in this document may be either trademarks and/or registered trademarks of the respective owners. The publisher and the author make no claim to these trademarks. While every precaution has been taken in the preparation of this document, the publisher and the author assume no responsibility for errors or omissions, or for damages resulting from the use of information contained in this document or from the use of programs and source code that may accompany it. In no event shall the publisher and the author be liable for any loss of profit or any other commercial damage caused or alleged to have been caused directly or indirectly by this document. Printed: Mai 2018 Mercury Manual Contents I Table of Contents 1 Introduction 10 2 Requirements 10 3 Installation & Licensing 11 4 Principles 13 4...1....Components.................... ........................................................................................................ 13 4...2....The...... .Standard.............. ..Application................. .................................................................................... 13 4...3....Input........ .Interface.............. .In... .Detail......... ......................................................................................
    [Show full text]
  • United States Court of Appeals for the SECOND CIRCUIT
    15-2675 IN THE United States Court of Appeals FOR THE SECOND CIRCUIT UNITED STATES OF AMERICA, Appellee, v. JORGE LAFONTAINE, JOSE LAFONTAINE, JOSE ISMAEL VENTURA, AKA MAELO, Defendants, KEVIN VENTURA, Defendant-Appellant. ON APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK (NEW YORK CITY) OPENING BRIEF OF APPELLANT & SPECIAL APPENDIX John C. Meringolo MERINGOLO & ASSOCIATES, P.C. 11 Evans Street Brooklyn, NY 11201 347-599-0992 Counsel for Appellant LANTAGNE LEGAL PRINTING 801 East Main Street Suite 100 Richmond, Virginia 23219 (804) 644-0477 A Division of Lantagne Duplicating Services TABLE OF CONTENTS TABLE OF CONTENTS ........................................................................................... i TABLE OF AUTHORITIES ................................................................................... iv JURISDICTIONAL STATEMENT .......................................................................... 1 STATEMENT OF THE ISSUES PRESENTED FOR REVIEW ............................. 1 STATEMENT OF THE CASE .................................................................................. 3 I. The Evidence At Trial ....................................................................................... 5 A. The Marijuana Conspiracy ........................................................................... 5 B. The Arson and Felony Murder of Noel Montanez ....................................... 5 C. The Conspiracy and Murder-for-Hire of Eugene Garrido and Carlos Penzo ................................................................................................
    [Show full text]
  • User Guide 7010 Thermal Printer
    User Guide 7010 Thermal Printer 7010 7010R 7010-300 CONTENTS Before Operation INTRODUCTION - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3 COMPLIANCE STATEMENT FOR EUROPEAN USERS - - - - - - - - - - - - - - - - - - 4 FCC COMPLIANCE STATEMENT FOR AMERICAN USERS - - - - - - - - - - - - - - 4 EMI COMPLIANCE STATEMENT FOR CANADIAN USERS- - - - - - - - - - - - - - - 5 ETAT DE CONFORMITE EMI A L’USAGE DES UTILISATEURS CANADIENS - 5 IMPORTANT SAFETY INSTRUCTIONS - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 6 NOTICE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 7 SAFETY INSTRUCTIONS - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 8 Chapter 1 Setup Confirmation of Carton Contents - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 10 Part Names and Functions - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 11 Connection to Power - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 18 Driver Installation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 18 Connection to a Computer - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 19 Chapter 2 Printer Operation Power ON/OFF - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 20 Normal Operating Mode - - - - - - - - - - - - - - - - - - - - - - - - -
    [Show full text]
  • Tla Hearing Board
    TLA HEARING BOARD Hearing Schedule from 01/11/2019 to 30/11/2019 Location: DELHI Hearing Timing : 10.30 am to 1.00 pm S.No TM No Class Hearing Proprietor Name Agent Name Mode of Date Hearing 1 3261817 7 04-11-2019 MR. RAJESH KUMAR, MR. RAVI KUMAR & MR. BASSI & ASSOCIATES Physical RAVINDER KUMAR 2 3455775 35 04-11-2019 S. AVTAR SINGH MANN BASSI & ASSOCIATES Physical 3 3462686 5 04-11-2019 MR. ARVIND CHOPRA BASSI & ASSOCIATES Physical 4 3466169 29 04-11-2019 MR. TARSEM CHAND BASSI & ASSOCIATES Physical 5 3480925 25 04-11-2019 MR. LOKESH JAIN BASSI & ASSOCIATES Physical 6 3090419 3 04-11-2019 VISAGE BEAUTY & HEALTH CARE (P) LTD. VUTTS & ASSOCIATES Physical 7 3098412 41 04-11-2019 AKSHAYA SINGH CHAUHAN VUTTS & ASSOCIATES Physical 8 3174528 39 04-11-2019 DIMERCO EXPRESS CORPORATION VUTTS & ASSOCIATES Physical 9 3225886 99 04-11-2019 PROFESSIONAL LIABILITY UNDERWRITING VUTTS & ASSOCIATES Physical SOCIETY 10 3053893 38 04-11-2019 IOTALINKS ENTERPRISES PRIVATE LIMITED LEGASIS PARTNERS Physical 11 3060237 16 04-11-2019 R K VERMA PRAMOD KUMAR KAPOOR Physical (ADVOCATE) 12 3116141 25 04-11-2019 PRAVEEN GOYAL PRAMOD KUMAR KAPOOR Physical (ADVOCATE) 13 3116145 21 04-11-2019 K STORE THE CROCKERY LOUNGE PRAMOD KUMAR KAPOOR Physical (ADVOCATE) 14 3121869 5 04-11-2019 ANIL KUMAR BANSAL PRAMOD KUMAR KAPOOR Physical (ADVOCATE) 15 3282395 24 04-11-2019 MR. RAGHAVENDRA RATHORE LEGALESE LAW FIRM Physical 16 3439855 4 04-11-2019 NEPTUNE LUBS INDIA LTD PRAMOD KUMAR KAPOOR Physical (ADVOCATE) 17 3462796 12 04-11-2019 MAHARASHTRA AUTO AGENCIES PRAMOD KUMAR KAPOOR Physical (ADVOCATE) 18 3464626 25 04-11-2019 KISHAN PAL SAINI PRAMOD KUMAR KAPOOR Physical (ADVOCATE) 19 3467746 30 04-11-2019 URBAN FOODS PRAMOD KUMAR KAPOOR Physical (ADVOCATE) 20 3472834 5 04-11-2019 VEDIC UPCHAR PVT LTD.
    [Show full text]
  • Ventura International Shares Fund Product Disclosure Statement ARSN 099 585 145 APIR VEN0031AU Issue Date 28 September 2017
    Ventura International Shares Fund Product Disclosure Statement ARSN 099 585 145 APIR VEN0031AU Issue Date 28 September 2017 About this PDS Contents This Product Disclosure Statement (“PDS”) has been prepared and issued by Equity Trustees Limited (“Equity Trustees”, “we” or “Responsible Entity”) and is a summary of the 1. About Equity Trustees Limited significant information relating to an investment in the Ventura International Shares Fund 2. How the Ventura International (the “Fund”). It contains a number of references to important information (including a Shares Fund works glossary of terms) contained in the Ventura Reference Guide (“Reference Guide”), which 3. Benefits of investing in the forms part of this PDS. You should consider both the information in this PDS, and the Ventura International Shares information in the Reference Guide, before making a decision about investing in the Fund. Fund The offer to which this PDS relates is only available to persons receiving this PDS (electronically or otherwise) in Australia. 4. Risks of managed investment schemes This PDS does not constitute a direct or indirect offer of securities in the US or to any US Person as defined in Regulation S under the US Securities Act of 1933 as amended (“US 5. How we invest your money Securities Act”). Equity Trustees may vary this position and offers may be accepted on merit 6. Fees and costs at Equity Trustees’ discretion. The units in the Fund have not been, and will not be, 7. How managed investment registered under the US Securities Act unless otherwise approved by Equity Trustees and schemes are taxed may not be offered or sold in the US to, or for, the account of any US Person except in a transaction that is exempt from the registration requirements of the US Securities Act and 8.
    [Show full text]
  • Trade Marks Journal No: 1815 , 18/09/2017 Class 12
    Trade Marks Journal No: 1815 , 18/09/2017 Class 12 CAMEO 1974865 03/06/2010 PRINCE BANSAL trading as ;PRINCE INTERNATIONAL F -284, PHASE -VIII, FOCAL POINT, NICHI MANGLI, LUDHIANA - 141010, PUNJAB MERCHANTS & MANUFACTURERS Address for service in India/Agents address: MAHTTA & CO. 43 - B/3, MAHTTA HOUSE,UDHAM SINGH NAGAR, LUDHIANA - 141 001, (PUNJAB). Used Since :01/04/2006 DELHI BICYCLES AND PARTS THEREOF. 2602 Trade Marks Journal No: 1815 , 18/09/2017 Class 12 BRICA Priority claimed from 20/05/2010; Application No. : 85/043,971 ;United States of America 1981385 17/06/2010 BLUE RIDGE INTERNATIONAL PRODUCTS COMPANY trading as ;BLUE RIDGE INTERNATIONAL PRODUCTS COMPANY 225 BLUE RIDGE PARKWAY,POST OFFICE BOX 989,FREEPORT,FLORIDA 32439,U.S.A. MANUFACTURERS, MERCHANTS AND DISTRIBUTORS. A CORPORATION DULY ORGANIZED AND EXISTING UNDER THE LAWS OF THE STATE OF FLORIDA, UNITED STATES OF AMERICA. Address for service in India/Agents address: D. P. AHUJA & CO. 53, SYED AMIR ALI AVENUE, 4TH FLOOR, KOLKATA - 700 019, WEST BENGAL. Proposed to be Used KOLKATA AUTOMOBILE MIRRORS FOR ATTACHMENT INSIDE A VEHICLE FOR THE OBSERVATION OF THE VEHICLE"S INTERIOR; AUTOMOBILE SEAT BELT ADJUSTMENT SLEEVE FOR ADJUSTING THE FIT OF SEAT BELTS; AUTOMOBILE SEAT BELT ADJUSTMENT SLEEVE FOR ADJUSTING THE FIT OF SHOULDER BELTS; BABY STROLLERS; BOLSTER FOR USE IN A VEHICLE FOR LEVELING A CHILD"S SAFETY CAR SEAT; COMBINATION DRINK HOLDER AND SNACK TRAY FOR USE IN A VEHICLE; COMBINATION DRINK HOLDER AND SNACK TRAY THAT ATTACHES TO A STROLLER OR TO A SHOPPING CART HANDLE; CUSHIONS
    [Show full text]